Cash flow Philip Morris International, Inc.

Equities

PM

US7181721090

Tobacco

Market Closed - Nyse Other stock markets 01:30:02 18/04/2026 am IST			5-day change	1st Jan Change
157.79 ^USD	+0.99%		-1.66%	-1.63%

18/04	Philip Morris International announces U.S. FDA reauthorization of Iqos as a modified risk tobacco product	RE
18/04	Philip Morris International Announces U.S. FDA Reauthorization Of IQOS As A Modified Risk Tobacco Product	CI

3be713e1210fd1463011d63c7d0.GixJbFsaOTiiiEaZRfNqbUerIXdKtmuKDQRLTo8SXcI.V04mWwlRfn_PvTbdMbwEF3HsTAVy2SXZemU5EelQEbIjGz8LC2JIT-_Ncg

Published financial data: PHILIP MORRIS INTERNATIONAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	3.14TCr	3.18TCr	3.52TCr	3.79TCr	4.06TCr
Total Revenues	3.14TCr	3.18TCr	3.52TCr	3.79TCr	4.06TCr
Cost of Goods Sold, Total	1TCr	1.12TCr	1.29TCr	1.33TCr	1.34TCr
Gross Profit	2.14TCr	2.05TCr	2.23TCr	2.45TCr	2.73TCr
Selling General & Admin Expenses, Total	820.3Cr	804.9Cr	959.9Cr	1.13TCr	1.06TCr
Amortization of Goodwill and Intangible Assets - (IS)	9.6Cr	-	-	-	-
Other Operating Expenses, Total	829.9Cr	804.9Cr	959.9Cr	1.13TCr	1.06TCr
Operating Income	1.31TCr	1.25TCr	1.27TCr	1.32TCr	1.67TCr
Interest Expense, Total	-74Cr	-77Cr	-152.6Cr	-176.3Cr	-158.7Cr
Interest And Investment Income	11Cr	18Cr	46Cr	62Cr	62Cr
Net Interest Expenses	-63Cr	-59Cr	-106.1Cr	-114.3Cr	-97Cr
Income (Loss) On Equity Invest.	15Cr	14Cr	16Cr	64Cr	70Cr
Currency Exchange Gains (Loss)	-	-	-	58Cr	-155.7Cr
EBT, Excl. Unusual Items	1.26TCr	1.2TCr	1.18TCr	1.33TCr	1.49TCr
Restructuring Charges	-22Cr	-	-11Cr	-18Cr	-24Cr
Impairment of Goodwill	-	-	-66Cr	-	-4.1Cr
Gain (Loss) On Sale Of Investments	-	-	-	-231.6Cr	-
Gain (Loss) On Sale Of Assets	-	-	-	-10L	-
Asset Writedown	-	-11Cr	-1.5Cr	-22Cr	-4.1Cr
Legal Settlements	-	-	-20Cr	-4.5Cr	-
Other Unusual Items	-	-15Cr	-19Cr	-	-
EBT, Incl. Unusual Items	1.24TCr	1.18TCr	1.06TCr	1.05TCr	1.46TCr
Income Tax Expense	267.1Cr	224.4Cr	233.9Cr	301.7Cr	273.7Cr
Earnings From Continuing Operations	971Cr	952.7Cr	826.8Cr	750.3Cr	1.18TCr
Net Income to Company	971Cr	952.7Cr	826.8Cr	750.3Cr	1.18TCr
Minority Interest	-60Cr	-48Cr	-46Cr	-45Cr	-50Cr
Net Income - (IS)	910.9Cr	904.8Cr	781.3Cr	705.7Cr	1.13TCr
Preferred Dividend and Other Adjustments	2.6Cr	2.4Cr	2.2Cr	2.3Cr	3.2Cr
Net Income to Common Incl Extra Items	908.3Cr	902.4Cr	779.1Cr	703.4Cr	1.13TCr
Net Income to Common Excl. Extra Items	908.3Cr	902.4Cr	779.1Cr	703.4Cr	1.13TCr
Per Share Items
Net EPS - Basic	5.83	5.82	5.02	4.53	7.27
Basic EPS - Continuing Operations	5.83	5.82	5.02	4.53	7.27
Basic Weighted Average Shares Outstanding	155.8Cr	155Cr	155.2Cr	155.4Cr	155.6Cr
Net EPS - Diluted	5.83	5.81	5.02	4.52	7.26
Diluted EPS - Continuing Operations	5.83	5.81	5.02	4.52	7.26
Diluted Weighted Average Shares Outstanding	155.9Cr	155.2Cr	155.3Cr	155.6Cr	155.8Cr
Normalized Basic EPS	4.67	4.54	4.46	5.06	5.67
Normalized Diluted EPS	4.66	4.54	4.45	5.05	5.66
Dividend Per Share	4.9	5.04	5.14	5.3	5.64
Payout Ratio	83.21	86.34	101.93	116.15	76
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.41TCr	1.37TCr	1.41TCr	1.5TCr	1.87TCr
EBITA	1.32TCr	1.28TCr	1.32TCr	1.4TCr	1.77TCr
EBIT	1.31TCr	1.25TCr	1.27TCr	1.32TCr	1.67TCr
EBITDAR	1.44TCr	1.4TCr	1.44TCr	1.54TCr	1.91TCr
Total Revenues (As Reported)	3.14TCr	3.18TCr	-	-	-
Effective Tax Rate - (Ratio)	21.57	19.06	22.05	28.68	18.77
Current Domestic Taxes	7.3Cr	-7.5Cr	20Cr	46Cr	40Cr
Current Foreign Taxes	261.6Cr	255.3Cr	246.8Cr	266.8Cr	318.2Cr
Total Current Taxes	268.9Cr	247.8Cr	266.9Cr	313.3Cr	358.4Cr
Deferred Domestic Taxes	2.7Cr	-14Cr	-37Cr	-8.1Cr	-86Cr
Deferred Foreign Taxes	-4.5Cr	-9.5Cr	3.8Cr	-3.5Cr	1Cr
Total Deferred Taxes	-1.8Cr	-23Cr	-33Cr	-12Cr	-85Cr
Normalized Net Income	727.21Cr	704.22Cr	691.56Cr	785.84Cr	881.75Cr
Interest on Long-Term Debt	10L	10L	10L	20L	20L
Non-Cash Pension Expense	-10L	-9.3Cr	-8.4Cr	-7.6Cr	-8.8Cr
Supplemental Operating Expense Items
Advertising Expense	81Cr	78Cr	96Cr	106.9Cr	135.5Cr
Research And Development Expense From Footnotes	62Cr	64Cr	71Cr	76Cr	76Cr
Net Rental Expense, Total	34Cr	33Cr	35Cr	37Cr	41Cr
Imputed Operating Lease Interest Expense	6.6Cr	5.63Cr	9.32Cr	11Cr	11Cr
Imputed Operating Lease Depreciation	27Cr	27Cr	26Cr	26Cr	30Cr
Stock-Based Comp., Other (Total)	21Cr	18Cr	21Cr	23Cr	25Cr
Total Stock-Based Compensation	21Cr	18Cr	21Cr	23Cr	25Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	449.6Cr	320.7Cr	306Cr	421.6Cr	487.2Cr
Trading Asset Securities, Total	-	-	10L	-	-
Total Cash And Short Term Investments	449.6Cr	320.7Cr	306.1Cr	421.6Cr	487.2Cr
Accounts Receivable, Total	312.3Cr	385Cr	346.1Cr	378.9Cr	457.2Cr
Other Receivables	82Cr	91Cr	93Cr	89Cr	123.8Cr
Total Receivables	394Cr	475.6Cr	439.1Cr	467.5Cr	581Cr
Inventory	872Cr	988.6Cr	1.08TCr	945.3Cr	1.15TCr
Restricted Cash	40L	1Cr	8.6Cr	3.8Cr	2Cr
Other Current Assets, Total	56Cr	176Cr	144.3Cr	178.8Cr	218.3Cr
Total Current Assets	1.77TCr	1.96TCr	1.98TCr	2.02TCr	2.44TCr
Gross Property Plant And Equipment	1.53TCr	1.6TCr	1.77TCr	1.73TCr	2.03TCr
Accumulated Depreciation	-856.4Cr	-873.3Cr	-956.4Cr	-937.5Cr	-1.12TCr
Net Property Plant And Equipment	669.4Cr	730.4Cr	814.7Cr	789.5Cr	907.6Cr
Long-term Investments	446.3Cr	443.1Cr	492.9Cr	265.8Cr	296.8Cr
Goodwill	668Cr	1.97TCr	1.68TCr	1.66TCr	1.73TCr
Other Intangibles, Total	281.8Cr	673.2Cr	986.4Cr	1.13TCr	1.09TCr
Deferred Tax Assets Long-Term	90Cr	60Cr	81Cr	94Cr	124.7Cr
Other Long-Term Assets, Total	202.3Cr	333.7Cr	501.6Cr	219.4Cr	338.3Cr
Total Assets	4.13TCr	6.17TCr	6.53TCr	6.18TCr	6.92TCr
Liabilities
Accounts Payable, Total	333.1Cr	407.6Cr	414.3Cr	395.2Cr	440.7Cr
Accrued Expenses, Total	950.4Cr	1.14TCr	1.13TCr	1.17TCr	1.27TCr
Short-term Borrowings	22Cr	563.7Cr	196.8Cr	14Cr	17Cr
Current Portion of Long-Term Debt	275Cr	257.7Cr	474.6Cr	340.5Cr	352.5Cr
Current Portion of Leases	24Cr	21Cr	23Cr	21Cr	24Cr
Current Income Taxes Payable	102.5Cr	104Cr	115.8Cr	125.8Cr	125.5Cr
Other Current Liabilities	218Cr	241.2Cr	280Cr	227.2Cr	313.1Cr
Total Current Liabilities	1.93TCr	2.73TCr	2.64TCr	2.29TCr	2.54TCr
Long-Term Debt	2.48TCr	3.49TCr	4.12TCr	4.21TCr	4.51TCr
Long-Term Leases	37Cr	46Cr	48Cr	46Cr	58Cr
Pension & Other Post Retirement Benefits	214.9Cr	126Cr	221Cr	211.4Cr	145.9Cr
Deferred Tax Liability Non Current	73Cr	195.6Cr	233.5Cr	251.7Cr	206.5Cr
Other Non Current Liabilities	224.1Cr	212.9Cr	210.5Cr	151.2Cr	260.2Cr
Total Liabilities	4.95TCr	6.8TCr	7.48TCr	7.17TCr	7.72TCr
Additional Paid In Capital	222.5Cr	223Cr	228.5Cr	233.5Cr	245.3Cr
Retained Earnings	3.31TCr	3.43TCr	3.41TCr	3.29TCr	3.54TCr
Treasury Stock	-3.58TCr	-3.59TCr	-3.58TCr	-3.56TCr	-3.56TCr
Comprehensive Income and Other	-957.7Cr	-955.9Cr	-1.18TCr	-1.13TCr	-1.23TCr
Total Common Equity	-1.01TCr	-895.7Cr	-1.12TCr	-1.18TCr	-999.4Cr
Minority Interest	189.8Cr	264.6Cr	177.9Cr	188Cr	196.6Cr
Total Equity	-820.8Cr	-631.1Cr	-944.6Cr	-987Cr	-802.8Cr
Total Liabilities And Equity	4.13TCr	6.17TCr	6.53TCr	6.18TCr	6.92TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	154.98Cr	155.02Cr	155.25Cr	155.49Cr	155.67Cr
ECS Total Common Shares Outstanding	155.02Cr	155.02Cr	155.24Cr	155.48Cr	155.67Cr
Book Value / Share	-6.52	-5.78	-7.23	-7.56	-6.42
Tangible Book Value	-1.96TCr	-3.53TCr	-3.79TCr	-3.97TCr	-3.81TCr
Tangible Book Value Per Share	-12.65	-22.8	-24.39	-25.52	-24.5
Total Debt	2.83TCr	4.37TCr	4.87TCr	4.64TCr	4.96TCr
Net Debt	2.38TCr	4.05TCr	4.56TCr	4.21TCr	4.47TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	166.1Cr	67Cr	171.6Cr	142.6Cr	32Cr
Debt Equivalent Oper. Leases	271.2Cr	264Cr	282.4Cr	299.2Cr	326.4Cr
Minority Interest, Total (Incl. Fin. Div)	189.8Cr	264.6Cr	177.9Cr	188Cr	196.6Cr
Equity Method Investments, Total	88Cr	100Cr	130.9Cr	100.5Cr	101.9Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	329.4Cr	370.2Cr	423.5Cr	434.1Cr	464.8Cr
Inventories - Finished Goods, Total	542.6Cr	618.4Cr	653.9Cr	511.2Cr	683Cr
Land - (BS)	56Cr	54Cr	55Cr	58Cr	56Cr
Buildings, Total	429.3Cr	429.1Cr	461.7Cr	439.1Cr	505Cr
Machinery, Total	927.5Cr	954.9Cr	1.07TCr	1.06TCr	1.25TCr
Full Time Employees	69.6T	79.8T	82.7T	83.1T	84.9T
Accumulated Allowance for Doubtful Accounts (Supple)	7Cr	4.2Cr	7.9Cr	4.7Cr	2.3Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	910.9Cr	904.8Cr	781.3Cr	705.7Cr	1.13TCr
Depreciation & Amortization - CF	90Cr	92Cr	90Cr	95Cr	99Cr
Amortization of Goodwill and Intangible Assets - (CF)	9.6Cr	27Cr	50Cr	84Cr	100.3Cr
Depreciation & Amortization, Total	100Cr	118.9Cr	139.8Cr	178.7Cr	199.6Cr
(Gain) Loss From Sale Of Asset	-	-	-	21Cr	9.4Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	231.6Cr	-
Asset Writedown & Restructuring Costs	-2.2Cr	-9.3Cr	71Cr	15Cr	25Cr
Other Operating Activities, Total	52Cr	50Cr	58Cr	2.5Cr	36Cr
Change In Accounts Receivable	-20Cr	-87Cr	31Cr	-74Cr	-45Cr
Change In Inventories	55Cr	-128.7Cr	-86Cr	55Cr	-120.1Cr
Change In Accounts Payable	65Cr	72Cr	-29Cr	30Cr	26Cr
Change In Income Taxes	-26Cr	-26Cr	-23Cr	-6.2Cr	-27Cr
Change in Other Net Operating Assets	62Cr	186.2Cr	-23Cr	63Cr	-15Cr
Cash from Operations	1.2TCr	1.08TCr	920.4Cr	1.22TCr	1.22TCr
Capital Expenditure	-75Cr	-107.7Cr	-132.1Cr	-144.4Cr	-156.9Cr
Cash Acquisitions	-211.1Cr	-1.5TCr	-177.5Cr	4.3Cr	-
Divestitures	-	-	-	14Cr	3Cr
Investment in Marketable and Equity Securities, Total	-3.4Cr	-2Cr	-11Cr	-12Cr	-15Cr
Other Investing Activities, Total	54Cr	40Cr	-39Cr	30Cr	-227.9Cr
Cash from Investing	-235.8Cr	-1.57TCr	-359.8Cr	-109.2Cr	-396.7Cr
Short Term Debt Issued, Total	-	1.57TCr	189.6Cr	10Cr	19Cr
Long-Term Debt Issued, Total	-	596.5Cr	995.9Cr	814.2Cr	705.5Cr
Total Debt Issued	-	2.17TCr	1.19TCr	824.2Cr	724.4Cr
Short Term Debt Repaid, Total	-	-479.5Cr	-560.2Cr	-506.2Cr	-17Cr
Long-Term Debt Repaid, Total	-304.2Cr	-272.4Cr	-255.1Cr	-480.3Cr	-536.8Cr
Total Debt Repaid	-304.2Cr	-751.9Cr	-815.3Cr	-986.5Cr	-553.8Cr
Repurchase of Common Stock	-78Cr	-21Cr	-	-	-
Common Dividends Paid	-758Cr	-781.2Cr	-796.4Cr	-819.7Cr	-862.4Cr
Common & Preferred Stock Dividends Paid	-758Cr	-781.2Cr	-796.4Cr	-819.7Cr	-862.4Cr
Other Financing Activities, Total	-58Cr	-234.9Cr	-132Cr	34Cr	-121.4Cr
Cash from Financing	-1.2TCr	380.6Cr	-558.2Cr	-948.1Cr	-813.2Cr
Foreign Exchange Rate Adjustments	-42Cr	-21Cr	-9.5Cr	-54Cr	50Cr
Net Change in Cash	-278.5Cr	-128.3Cr	-7.1Cr	110.8Cr	64Cr
Supplemental Items
Cash Interest Paid	72Cr	72Cr	134.2Cr	155.9Cr	168.8Cr
Cash Income Tax Paid (Refund)	293.6Cr	275.1Cr	295.2Cr	317.8Cr	385.2Cr
Levered Free Cash Flow	914.59Cr	729.71Cr	754.79Cr	818.45Cr	893.89Cr
Unlevered Free Cash Flow	960.65Cr	777.71Cr	850.16Cr	928.64Cr	993.08Cr
Change In Net Working Capital	-97Cr	32Cr	-28Cr	-46Cr	120.4Cr
Net Debt Issued / Repaid	-304.2Cr	1.42TCr	370.2Cr	-162.3Cr	170.6Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	18.98	15.16	12.5	13	15.96
Return on Total Capital	39.15	27.11	20.69	21.82	26.79
Return On Equity %	-103.08	-131.23	-104.94	-77.69	-132.39
Return on Common Equity	-80.12	-94.68	-77.21	-61.23	-104.08
Margin Analysis
Gross Profit Margin %	68.06	64.65	63.39	64.81	67.12
SG&A Margin	26.12	25.34	27.29	29.92	25.97
EBITDA Margin %	44.81	43.05	40.07	39.61	46.06
EBITA Margin %	41.94	40.16	37.51	37.09	43.62
EBIT Margin %	41.64	39.31	36.1	34.89	41.15
Income From Continuing Operations Margin %	30.92	29.99	23.51	19.81	29.15
Net Income Margin %	29	28.49	22.21	18.63	27.92
Net Avail. For Common Margin %	28.92	28.41	22.15	18.57	27.84
Normalized Net Income Margin	23.16	22.17	19.66	20.75	21.69
Levered Free Cash Flow Margin	29.12	22.97	21.46	21.61	21.99
Unlevered Free Cash Flow Margin	30.59	24.49	24.17	24.52	24.43
Asset Turnover
Asset Turnover	0.73	0.62	0.55	0.6	0.62
Fixed Assets Turnover	4.57	4.54	4.55	4.72	4.79
Receivables Turnover (Average Receivables)	10.42	9.11	9.62	10.45	9.72
Inventory Turnover (Average Inventory)	1.1	1.21	1.25	1.32	1.28
Short Term Liquidity
Current Ratio	0.92	0.72	0.75	0.88	0.96
Quick Ratio	0.44	0.29	0.28	0.39	0.42
Operating Cash Flow to Current Liabilities	0.62	0.4	0.35	0.53	0.48
Days Sales Outstanding (Average Receivables)	35.03	40.07	37.93	35.03	37.54
Days Outstanding Inventory (Average Inventory)	333.18	302.42	292.78	277.71	285.79
Average Days Payable Outstanding	121.77	109.07	108.96	123.37	99.12
Cash Conversion Cycle (Average Days)	246.44	233.42	221.75	189.37	224.21
Long Term Solvency
Total Debt/Equity	-345.3	-693.03	-515.12	-469.63	-617.78
Total Debt / Total Capital	140.77	116.86	124.09	127.05	119.31
LT Debt/Equity	-306.13	-559.52	-441.64	-431.57	-568.76
Long-Term Debt / Total Capital	124.8	94.35	106.39	116.76	109.85
Total Liabilities / Total Assets	119.88	110.23	114.46	115.98	111.6
EBIT / Interest Expense	17.74	16.26	8.32	7.5	10.54
EBITDA / Interest Expense	19.56	18.23	9.47	8.72	12.05
(EBITDA - Capex) / Interest Expense	18.54	16.83	8.6	7.9	11.07
Total Debt / EBITDA	1.97	3.12	3.37	3.01	2.59
Net Debt / EBITDA	1.65	2.89	3.16	2.74	2.34
Total Debt / (EBITDA - Capex)	2.07	3.38	3.71	3.33	2.82
Net Debt / (EBITDA - Capex)	1.75	3.14	3.47	3.02	2.55
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.45	1.14	10.74	7.69	7.31
Gross Profit, 1 Yr. Growth %	11.76	-3.93	8.58	9.91	11.13
EBITDA, 1 Yr. Growth %	10.81	-2.84	3.48	2.18	24.8
EBITA, 1 Yr. Growth %	11.69	-3.16	3.87	1.95	26.18
EBIT, 1 Yr. Growth %	11.57	-4.52	1.22	-0.52	26.57
Earnings From Cont. Operations, 1 Yr. Growth %	13.01	-1.88	-13.22	-9.25	57.91
Net Income, 1 Yr. Growth %	13.07	-0.67	-13.65	-9.68	60.8
Normalized Net Income, 1 Yr. Growth %	13.4	-3.16	-2.31	13.23	12.21
Diluted EPS Before Extra, 1 Yr. Growth %	12.98	-0.34	-13.6	-9.96	60.62
Accounts Receivable, 1 Yr. Growth %	7.5	23.28	-10.1	9.48	20.66
Inventory, 1 Yr. Growth %	-9.08	13.37	8.98	-12.26	21.42
Net Property, Plant and Equip., 1 Yr. Growth %	-5.21	9.11	11.54	-3.09	14.96
Total Assets, 1 Yr. Growth %	-7.87	49.38	5.87	-5.39	11.98
Tangible Book Value, 1 Yr. Growth %	-4.6	80.29	7.14	4.78	-3.87
Common Equity, 1 Yr. Growth %	-19.58	-11.37	25.32	4.68	-14.94
Cash From Operations, 1 Yr. Growth %	21.96	-9.73	-14.8	32.74	0.13
Capital Expenditures, 1 Yr. Growth %	24.25	43.98	22.66	9.31	8.66
Levered Free Cash Flow, 1 Yr. Growth %	5.56	-20.21	4.9	3.41	9.22
Unlevered Free Cash Flow, 1 Yr. Growth %	5.35	-19.04	10.77	4.71	6.94
Dividend Per Share, 1 Yr. Growth %	3.38	2.86	1.98	3.11	6.42
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.65	5.21	5.83	9.2	7.5
Gross Profit, 2 Yr. CAGR %	5.26	3.62	2.13	9.01	10.65
EBITDA, 2 Yr. CAGR %	8.2	3.76	0.07	3.94	13.13
EBITA, 2 Yr. CAGR %	8.82	4.33	0.45	4.74	15.76
EBIT, 2 Yr. CAGR %	8.74	3.21	-1.46	1.58	12.44
Earnings From Cont. Operations, 2 Yr. CAGR %	12.09	5.3	-7.72	-11.26	19.71
Net Income, 2 Yr. CAGR %	12.6	5.98	-7.39	-11.69	20.52
Normalized Net Income, 2 Yr. CAGR %	9.14	4.79	-2.48	4.78	12.99
Diluted EPS Before Extra, 2 Yr. CAGR %	12.46	6.11	-7.21	-11.8	20.26
Accounts Receivable, 2 Yr. CAGR %	0.7	15.12	5.27	-0.8	14.94
Inventory, 2 Yr. CAGR %	-2.83	1.53	11.16	-2.21	3.22
Net Property, Plant and Equip., 2 Yr. CAGR %	-4.87	1.7	10.32	3.97	5.55
Total Assets, 2 Yr. CAGR %	-1.87	17.32	25.76	0.08	2.93
Tangible Book Value, 2 Yr. CAGR %	0.14	31.14	38.98	5.95	0.36
Common Equity, 2 Yr. CAGR %	-6.57	-15.58	5.39	14.53	-5.64
Cash From Operations, 2 Yr. CAGR %	8.9	4.93	-12.3	6.34	15.29
Capital Expenditures, 2 Yr. CAGR %	-6.3	33.75	32.89	15.79	8.98
Levered Free Cash Flow, 2 Yr. CAGR %	8.73	-8.23	-9.16	5.45	6.5
Unlevered Free Cash Flow, 2 Yr. CAGR %	8.01	-7.65	-5.93	8.83	6.02
Dividend Per Share, 2 Yr. CAGR %	2.99	3.12	2.42	2.55	4.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.96	2.14	7.02	6.45	8.57
Gross Profit, 3 Yr. CAGR %	4.25	2.1	5.25	4.72	9.71
EBITDA, 3 Yr. CAGR %	4.52	4.39	3.53	2.15	10.48
EBITA, 3 Yr. CAGR %	4.88	4.67	4.03	2.42	11.45
EBIT, 3 Yr. CAGR %	4.87	4.13	2.7	0.35	9.3
Earnings From Cont. Operations, 3 Yr. CAGR %	5.43	7.22	-1.27	-8.24	7.54
Net Income, 3 Yr. CAGR %	4.81	7.99	-1.02	-8.16	7.84
Normalized Net Income, 3 Yr. CAGR %	4.72	4.88	2.55	2.62	7.2
Diluted EPS Before Extra, 3 Yr. CAGR %	4.72	8.02	-0.91	-8.13	7.71
Accounts Receivable, 3 Yr. CAGR %	1.92	7.72	6.01	6.66	5.9
Inventory, 3 Yr. CAGR %	-0.32	2.3	3.95	2.73	5.1
Net Property, Plant and Equip., 3 Yr. CAGR %	-2.4	-0.42	4.88	5.65	7.51
Total Assets, 3 Yr. CAGR %	1.23	12.89	13.37	14.38	3.9
Tangible Book Value, 3 Yr. CAGR %	-3.66	21.83	22.6	26.49	2.57
Common Equity, 3 Yr. CAGR %	-6.74	-8.2	-3.69	5.15	3.72
Cash From Operations, 3 Yr. CAGR %	8.08	2.3	-2.11	0.69	4.23
Capital Expenditures, 3 Yr. CAGR %	-19.54	8.12	29.95	24.52	13.36
Levered Free Cash Flow, 3 Yr. CAGR %	15.15	-1.93	-4.49	-3.63	6.69
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.77	-1.89	-2.31	-1.12	8.2
Dividend Per Share, 3 Yr. CAGR %	2.96	2.94	2.74	2.65	3.82
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.31	2.01	3.49	4.91	7.21
Gross Profit, 5 Yr. CAGR %	4.33	2.31	3.4	4.94	7.36
EBITDA, 5 Yr. CAGR %	4.02	2.01	2.72	4.53	8.07
EBITA, 5 Yr. CAGR %	3.88	1.93	2.93	4.78	8.63
EBIT, 5 Yr. CAGR %	3.87	1.65	2.29	3.63	7.37
Earnings From Cont. Operations, 5 Yr. CAGR %	6.02	8.48	-0.04	-0.59	6.64
Net Income, 5 Yr. CAGR %	5.51	8.44	-0.25	-0.36	7.09
Normalized Net Income, 5 Yr. CAGR %	4	2.09	1.78	5.18	6.58
Diluted EPS Before Extra, 5 Yr. CAGR %	5.41	8.41	-0.23	-0.39	7.07
Accounts Receivable, 5 Yr. CAGR %	-2.25	3.81	3.25	4.23	9.49
Inventory, 5 Yr. CAGR %	-0.67	2.34	4.12	0.47	3.66
Net Property, Plant and Equip., 5 Yr. CAGR %	2	0.09	2.5	1.31	5.15
Total Assets, 5 Yr. CAGR %	2.3	7.5	10.41	7.58	9.07
Tangible Book Value, 5 Yr. CAGR %	-2.7	9.76	11.55	15.21	13.17
Common Equity, 5 Yr. CAGR %	-4.45	-5.82	-2.06	0.3	-4.48
Cash From Operations, 5 Yr. CAGR %	8.18	3.92	-0.58	3.9	4.51
Capital Expenditures, 5 Yr. CAGR %	-8.59	-7	-1.66	11.13	21.12
Levered Free Cash Flow, 5 Yr. CAGR %	9.06	4.32	4.73	1.13	0.63
Unlevered Free Cash Flow, 5 Yr. CAGR %	7.81	3.36	5.44	2.43	1.72
Dividend Per Share, 5 Yr. CAGR %	3.53	3.62	2.74	2.78	3.54